Medicine for treating haemorrhoids and preparation method thereof
Hemorrhoid ointment is prepared by mixing raw materials such as Citrus aurantium, benzoin, and sanitizing materials with auxiliary materials and crushing and sterilizing them. The problem of low treatment efficiency of existing hemorrhoid ointment is solved, and rapid hemostasis, pain relief and healing is achieved, which significantly reduces the number of hemorrhoid ointment. Improves the effectiveness of hemorrhoid treatment.
Patent Information
- Application Number
- CN202410912804.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-09
- Publication Date
- 2024-11-01
AI Technical Summary
The existing hemorrhoid cream is poor when used and needs to be applied for a long time, resulting in low treatment efficiency and ineffective and rapid relief of hemorrhoid symptoms.
Use a mixture of raw materials including Citrus aurantium, benzoin, squid and other raw materials with Vaseline, sesame oil, lanolin, liquid paraffin, and gel. It is prepared into hemorrhoid ointment after crushing, even mixing and ultraviolet sterilization to increase the friction and adsorption of drugs. Ability to destroy lesion tissue, adsorb toxic substances and bacteria, and promote metabolism.
It significantly improves the efficiency of hemorrhoid treatment, shortens the treatment time, and has the effect of rapid stopping hemorrhoids, relieves pain and promotes healing, which is significantly higher than traditional hemorrhoid cream. The patient has no pain after surgery and the onset time is significantly shortened.
Smart Images

Figure BDA0004934162290000061 
Figure BDA0004934162290000062
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of hemorrhoid medicines, in particular to a medicine for treating hemorrhoids and a preparation method thereof. Background Art
[0002] Hemorrhoids, commonly known as hemorrhoids, are common anorectal diseases caused by congestion or congestion and swelling of the venous plexus at the lower end of the anal canal or rectum. Hemorrhoids can be divided into external hemorrhoids, internal hemorrhoids and mixed hemorrhoids. The causes include downward displacement of anal cushions or varicose veins, as well as bad bowel habits, chronic diseases, low-fiber diet habits, etc. The existing hemorrhoid creams are less effective when used and need to be applied for a long time, which leads to the need for a longer treatment time at the site of the disease, reducing the working efficiency of the hemorrhoid cream. Summary of the invention
[0003] In view of the deficiencies in the prior art, the present invention provides a medicine for treating hemorrhoids and a preparation method thereof, which solves the technical problem that the existing hemorrhoid cream has poor effect when used and needs to be applied for a long time, thereby causing the patient's diseased area to require a long time of treatment, thereby reducing the working efficiency of the hemorrhoid cream.
[0004] To achieve the above purpose, the present invention is implemented through the following technical scheme: a medicine for treating hemorrhoids, comprising raw materials 20-180g of Citrus aurantium, 20-100g of benzoin and 20-180g of cuttlebone, and also comprising auxiliary materials 5-10g of vaseline, 5-10g of sesame oil, 5-10g of lanolin, 5-10g of liquid paraffin and 5-10g of gel.
[0005] A method for preparing a medicine for treating hemorrhoids comprises the following steps:
[0006] Step 1: Mix 20-180 g of the raw material, 20-100 g of benzoin and 20-180 g of cuttlebone, and grind them by a grinder;
[0007] Step 2: Take 5-10g of the crushed raw material and mix them evenly with auxiliary materials 5-10g of vaseline, 5-10g of sesame oil, 5-10g of lanolin, 5-10g of liquid paraffin, and 5-10g of gel to form 5 kinds of ointments;
[0008] Step 3: Sterilize the ointment;
[0009] Step 4: Package the sterilized ointment into finished products.
[0010] Preferably, the material after crushing in step 1 is sieved so that the powder can pass through a No. 6 sieve with 150 μm ± 6.6 μm and 100 mesh, and can also pass through a No. 7 sieve with 125 μm ± 5.8 μm and 120 mesh.
[0011] Preferably, at least 95% of the powder can pass through a No. 7 sieve of 125 μm ± 5.8 μm (120 mesh).
[0012] Preferably, the sterilization treatment in step three adopts ultraviolet disinfection.
[0013] Preferably, each portion of the ointment is 5-8 g when packaged in step 4.
[0014] Beneficial Effects
[0015] The invention provides a medicine for treating hemorrhoids and a preparation method, which solves the technical problem that the existing hemorrhoid cream has poor effect and needs to be applied for a long time during use, which leads to the patient's diseased area requiring a long time of treatment and reduces the working efficiency of the hemorrhoid cream. The hemorrhoid ointment of the invention is a medicine that mobilizes human immune cells to form highly consistent affinity antibodies, has good friction and adsorption effects, can destroy diseased epithelial tissues, adsorb toxic substances and blood with bacteria, etc., remove dead tissue and regenerate flesh, eliminate filth and open the mind, and promote metabolism. DETAILED DESCRIPTION
[0016] The present invention will be further described below in conjunction with embodiments;
[0017] Example 1: A medicine for treating hemorrhoids, comprising raw materials of 20-180g of Citrus aurantium immaturus, 20-100g of benzoin and 20-180g of cuttlebone, and also comprising auxiliary materials of 5-10g of vaseline, 5-10g of sesame oil, 5-10g of lanolin, 5-10g of liquid paraffin and 5-10g of gel:
[0018] Step 1: 20-180g of the raw material, 20-100g of benzoin and 20-180g of cuttlebone are mixed, and then crushed by a pulverizer so that the powder can pass through a No. 6 sieve of 150μm±6.6μm, which is 100 mesh, and can also pass through a No. 7 sieve of 125μm±5.8μm, which is 120 mesh, and the powder that can pass through a No. 7 sieve of 125μm±5.8μm, which is 120 mesh, is not less than 95%;
[0019] Step 2: Take 5-10g of the crushed raw material and mix it with 5-10g of the auxiliary material vaseline to form an ointment;
[0020] Step 3: sterilize the ointment using ultraviolet disinfection;
[0021] Step 4: Package the sterilized ointment into finished products, with each portion of ointment being 5-8g.
[0022] Example 2: A medicine for treating hemorrhoids, comprising raw materials of 20-180g of Citrus aurantium immaturus, 20-100g of benzoin and 20-180g of cuttlebone, and also comprising auxiliary materials of 5-10g of vaseline, 5-10g of sesame oil, 5-10g of lanolin, 5-10g of liquid paraffin and 5-10g of gel:
[0023] Step 1: 20-180g of the raw material, 20-100g of benzoin and 20-180g of cuttlebone are mixed, and then crushed by a pulverizer so that the powder can pass through a No. 6 sieve of 150μm±6.6μm, which is 100 mesh, and can also pass through a No. 7 sieve of 125μm±5.8μm, which is 120 mesh, and the powder that can pass through a No. 7 sieve of 125μm±5.8μm, which is 120 mesh, is not less than 95%;
[0024] Step 2: Take 5-10g of the crushed raw material and mix it with 5-10g of sesame oil as an auxiliary material to form an ointment;
[0025] Step 3: sterilize the ointment using ultraviolet disinfection;
[0026] Step 4: Package the sterilized ointment into finished products, with each portion of ointment being 5-8g.
[0027] Example 3: A medicine for treating hemorrhoids, comprising raw materials of 20-180g of Citrus aurantium immaturus, 20-100g of benzoin and 20-180g of cuttlebone, and also comprising auxiliary materials of 5-10g of vaseline, 5-10g of sesame oil, 5-10g of lanolin, 5-10g of liquid paraffin and 5-10g of gel:
[0028] Step 1: 20-180g of the raw material, 20-100g of benzoin and 20-180g of cuttlebone are mixed, and then crushed by a pulverizer so that the powder can pass through a No. 6 sieve of 150μm±6.6μm, which is 100 mesh, and can also pass through a No. 7 sieve of 125μm±5.8μm, which is 120 mesh, and the powder that can pass through a No. 7 sieve of 125μm±5.8μm, which is 120 mesh, is not less than 95%;
[0029] Step 2: Take 5-10g of the crushed raw material and mix it with 5-10g of lanolin to form an ointment;
[0030] Step 3: sterilize the ointment using ultraviolet disinfection;
[0031] Step 4: Package the sterilized ointment into finished products, with each portion of ointment being 5-8g.
[0032] Example 4: A medicine for treating hemorrhoids, comprising raw materials of 20-180g of Citrus aurantium immaturus, 20-100g of benzoin and 20-180g of cuttlebone, and also comprising auxiliary materials of 5-10g of vaseline, 5-10g of sesame oil, 5-10g of lanolin, 5-10g of liquid paraffin and 5-10g of gel:
[0033] Step 1: 20-180g of the raw material, 20-100g of benzoin and 20-180g of cuttlebone are mixed, and then crushed by a pulverizer so that the powder can pass through a No. 6 sieve of 150μm±6.6μm, which is 100 mesh, and can also pass through a No. 7 sieve of 125μm±5.8μm, which is 120 mesh, and the powder that can pass through a No. 7 sieve of 125μm±5.8μm, which is 120 mesh, is not less than 95%;
[0034] Step 2: Take 5-10g of the crushed raw material and mix it with 5-10g of liquid paraffin to form an ointment;
[0035] Step 3: sterilize the ointment using ultraviolet disinfection;
[0036] Step 4: Package the sterilized ointment into finished products, with each portion of ointment being 5-8g.
[0037] Example 5: A medicine for treating hemorrhoids, comprising raw materials of 20-180g of Citrus aurantium immaturus, 20-100g of benzoin and 20-180g of cuttlebone, and also comprising auxiliary materials of 5-10g of vaseline, 5-10g of sesame oil, 5-10g of lanolin, 5-10g of liquid paraffin and 5-10g of gel:
[0038] Step 1: 20-180g of the raw material, 20-100g of benzoin and 20-180g of cuttlebone are mixed, and then crushed by a pulverizer so that the powder can pass through a No. 6 sieve of 150μm±6.6μm, which is 100 mesh, and can also pass through a No. 7 sieve of 125μm±5.8μm, which is 120 mesh, and the powder that can pass through a No. 7 sieve of 125μm±5.8μm, which is 120 mesh, is not less than 95%;
[0039] Step 2: Take 5-10g of the crushed raw material and mix it evenly with 5-10g of the gel to form 5 kinds of ointments;
[0040] Step 3: sterilize the ointment using ultraviolet disinfection;
[0041] Step 4: Package the sterilized ointment into finished products, with each portion of ointment being 5-8g.
[0042] There are two types of comparative experiments for clinical applications:
[0043] 1. Medication for painless treatment after surgery.
[0044] 2. Use medication directly without surgery.
[0045] 1. Medication for pain relief after surgery
[0046] 1. Case selection: The patients were randomly divided into two groups. The experimental group included 30 cases with an average age of 37.5 years old, including 14 cases of internal hemorrhoids, 7 cases of external hemorrhoids, and 9 cases of mixed hemorrhoids, who were treated with this hemorrhoid ointment. The control group included 30 cases with an average age of 38.3 years old, including 6 cases of external hemorrhoids, 12 cases of internal hemorrhoids, and 12 cases of mixed hemorrhoids, who were treated with Mayinglong Hemorrhoid Ointment.
[0047] 2. Treatment method: The experimental group applied the hemorrhoid ointment to the affected area once a day, and the control group applied Mayinglong hemorrhoid ointment to the affected area once a day. Each course of treatment lasted ten days. All medications and physical therapy were discontinued during the observation period.
[0048] 3. Criteria for judging efficacy and observation items: The clinical symptoms and anoscopy results of both groups of patients were observed before and after treatment, and the evaluation was conducted according to the currently recognized standards:
[0049] Recovery: No pain after surgery, no bleeding after defecation, and anoscopy showed that the mucosa returned to normal.
[0050] Markedly effective: no bleeding after defecation and pain is significantly relieved.
[0051] Improvement: The pain after surgery was intermittent and more obvious during dressing changes.
[0052] Ineffective: persistent pain after surgery, delayed healing, and severe pain during dressing changes.
[0053] 2. Direct medication without surgery
[0054] 1. Case selection: According to the order of visiting doctors, the patients who meet the inclusion criteria are randomly divided into two groups, 19 cases in the control group, with an average age of 41.9 years old, 5 cases of external hemorrhoids, 6 cases of internal hemorrhoids, and 8 cases of mixed hemorrhoids, and Mayinglong Hemorrhoids Ointment is used for treatment. 19 cases in the experimental group, with an average age of 39.8 years old, 6 cases of external hemorrhoids, 5 cases of internal hemorrhoids, and 8 cases of mixed hemorrhoids, are treated with hemorrhoids ointment of the present invention.
[0055] 2. Treatment method: The control group was treated with Mayinglong hemorrhoid ointment, which was applied to the affected part once a day. The experimental group was treated with the hemorrhoid ointment of the present invention, which was applied to the affected part once a day. Every 7 days was a course of treatment, and all drugs and physical therapy were discontinued during the observation period.
[0056] 3. Criteria for judging efficacy: Clinical symptoms and anoscopy results were observed in both groups of patients before and after treatment.
[0057] Cured: No bleeding, pain or prolapse after defecation. Anoscopy showed that the mucosa returned to normal and the hemorrhoids atrophied.
[0058] Significant effect: no bleeding or prolapse after defecation, the redness and swelling of hemorrhoids significantly subsided, the pain disappeared, and anoscopy showed mild congestion of the internal hemorrhoidal mucosa and the hemorrhoids became smaller.
[0059] Progress: There is still a small amount of bleeding after defecation, the pain is relieved, accompanied by mild prolapse, and anoscopy shows mild congestion of the mucosa.
[0060] Ineffective: There was no significant improvement in clinical symptoms and anoscopy after medication compared with before treatment.
[0061] The experimental results are compared as follows:
[0062] Comparison of medication results after hemorrhoid surgery
[0063]
[0064] Comparison of results of direct medication without surgery
[0065]
[0066] Experimental conclusion and explanation
[0067] (1) Medication use after hemorrhoid surgery
[0068] The effective rate of the experimental group was 100%, and the effective rate of the control group was 64.3%, which was significantly higher than that of the control group. It shows that the ointment of the present invention has a significantly higher efficacy than Mayinglong Hemorrhoids Ointment in the surgical treatment of hemorrhoids. Among the 30 effective cases in the experimental group, the average onset time was 2.5 ± 5 hours (calculated in hours), all concentrated in 2-7 hours; while the average onset time of 28 cases in the control group was 3.57 ± 1.43 days (calculated in days), indicating that the hemorrhoids ointment of the present invention is significantly better than the control group in terms of onset time. The ointment invented by the experimental group has a faster and better hemostasis and analgesia effect, and truly achieves a veritable painless hemorrhoid surgery. The patient walked freely 3-4 hours after the operation. Although the dressing was changed once a day, there was no pain from the operation to complete recovery. Although the total effective rate of the control group was the same, it was faster in hemostasis, analgesia, healing, etc., and the frequency of dressing changes was significantly shortened.
[0069] (2) Non-surgical treatment with hemorrhoid cream
[0070] The treatment efficacy of the experimental group (100%) was significantly higher than that of the control group (52.5%), indicating that the ointment of the present invention is significantly better than Mayinglong Hemorrhoids Ointment in the treatment of hemorrhoids. Among the 19 effective cases in the experimental group, the average onset time was 0-6 hours (in hours), all concentrated in 1-4 hours after medication. The average onset time of the control group was 3.57 ± 1.43 days (in days), and the onset time of the experimental group was significantly higher than that of the control group. The experimental group had better hemostasis, analgesia, anti-inflammatory, detumescence, anti-itching, anal leakage, and hemorrhoid elimination.
[0071] It should be noted that, in this document, relational terms such as first and second, etc. are merely used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any actual relationship or order between these entities or operations.
Claims
1. A medicine for treating hemorrhoids, characterized in that: The invention comprises raw materials of 20-180g of Citrus aurantium immaturus, 20-100g of benzoin and 20-180g of cuttlebone, and also comprises auxiliary materials of 5-10g of vaseline, 5-10g of sesame oil, 5-10g of lanolin, 5-10g of liquid paraffin and 5-10g of gel.
2. A method for preparing a drug for treating hemorrhoids, characterized in that , including the following steps: Step 1: Mix 20-180 g of the raw material, 20-100 g of benzoin and 20-180 g of cuttlebone, and grind them by a grinder; Step 2: Take 5-10g of the crushed raw material and mix them evenly with auxiliary materials 5-10g of vaseline, 5-10g of sesame oil, 5-10g of lanolin, 5-10g of liquid paraffin, and 5-10g of gel to form 5 kinds of ointments; Step 3: Sterilize the ointment; Step 4: Package the sterilized ointment into finished products.
3. A method for preparing a medicine for treating hemorrhoids according to claim 2, characterized in that In the step 1, the crushed material is sieved so that the powder can pass through the No. 6 sieve with 150μm±6.6μm of 100 mesh and can also pass through the No. 7 sieve with 125μm±5.8μm of 120 mesh.
4. A method for preparing a medicine for treating hemorrhoids according to claim 3, characterized in that , the powder that can pass through the No. 7 sieve 125μm±5.8μm with a mesh size of 120 is not less than 95%.
5. A method for preparing a medicine for treating hemorrhoids according to claim 1, characterized in that ,The sterilization treatment in step three adopts ultraviolet disinfection.
6. A method for preparing a drug for treating hemorrhoids according to claim 1, characterized in that , each portion of the ointment is 5-8g when packaged in step 4.
Citation Information
Patent Citations
Medicament for curing external hemorrhoid
CN101524392A
Zhichuangling ointment and production technology
CN105148024A
